$0.1879
-0.0156-7.67%
Last update: Nov 5, 5:31 PM
Context Therapeutics Inc
CNTXNASDAQ
Context Therapeutics (CNTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.12 | $-0.11 | $-0.09 |
| Actual | $-0.15 | $-0.09 | $-0.14 | $-0.10 |
| Surprise | -66.7% | +25.0% | -27.3% | -11.1% |
| Revenue | ||||
| Estimate | — | — | $-1.5M | $-1.4M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | +100.0% | +100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.10 | $-0.11 | $-0.10 | $-0.09 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.15 | $-0.09 | -66.7 % |
| Q1 | May 6, 2026 | $-0.09 | $-0.12 | 25.0 % |
| Q4 | Mar 23, 2026 | $-0.14 | $-0.11 | -27.3 % |
| Q3 | Nov 5, 2025 | $-0.10 | $-0.09 | -11.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 23, 2026 | $0 | $-1.46M | 100.0 % |
| Q3 | Nov 5, 2025 | $0 | $-1.43M | 100.0 % |
